These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19104790)

  • 1. An analysis of the clinical development of drugs in Norway for the year 2000: the completion of research and publication of results.
    Hole OP; Nitter-Hauge S; Cederkvist HR; Winther FO
    Eur J Clin Pharmacol; 2009 Mar; 65(3):315-8. PubMed ID: 19104790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry.
    Winther FO; Hole OP; Nitter-Hauge S
    Eur J Clin Pharmacol; 2007 Oct; 63(10):909-12. PubMed ID: 17673994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical research projects at a German medical faculty: follow-up from ethical approval to publication and citation by others.
    Blümle A; Antes G; Schumacher M; Just H; von Elm E
    J Med Ethics; 2008 Sep; 34(9):e20. PubMed ID: 18757621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of pharmaceutical industry funding on clinical research.
    Lexchin JR
    Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 6. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 7. Shortcomings of protocols of drug trials in relation to sponsorship as identified by Research Ethics Committees: analysis of comments raised during ethical review.
    van Lent M; Rongen GA; Out HJ
    BMC Med Ethics; 2014 Dec; 15():83. PubMed ID: 25490963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving greater independence from commercial influence in research.
    Lexchin J; Bero LA; Davis C; Gagnon MA
    BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials in Norway--completion and reporting are not satisfactory].
    Sandaker L; Fjeld B; Reikvam A; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2888-90. PubMed ID: 15550958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of selective publication on clinical research in pain.
    Rowbotham MC
    Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
    [No Abstract]   [Full Text] [Related]  

  • 13. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflicts of interest in research involving human beings.
    Greco D; Diniz NM
    J Int Bioethique; 2008; 19(1-2):143-54, 202-3. PubMed ID: 18664007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health activists attack Indian compensation formula for deaths attributed to clinical trials.
    Mudur G
    BMJ; 2013 Oct; 347():f6295. PubMed ID: 24136639
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to open peer commentaries on "How to do research fairly in an unjust world".
    Ballantyne AJ
    Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 18. Can a good tree bring forth evil fruit? The funding of medical research by industry.
    Capps B
    Br Med Bull; 2016 Jun; 118(1):5-15. PubMed ID: 27151955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conflicts of interest--an evidence-based approach].
    Slørdal L; Eggen AE; Rygnestad T
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
    [No Abstract]   [Full Text] [Related]  

  • 20. Commentary: Professional responsibilities.
    Jacobs A
    Pharm Stat; 2011; 10(1):82. PubMed ID: 21275039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.